SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-23-003640
Filing Date
2023-06-20
Accepted
2023-06-20 16:30:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 ZENTALIS PHARMACEUTICALS, INC. p23-1815sc13da.htm SC 13D/A 49469
  Complete submission text file 0000902664-23-003640.txt   51294
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Filed by) CIK: 0001410830 (see all company filings)

IRS No.: 043475951 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91478 | Film No.: 231025567
SIC: 2834 Pharmaceutical Preparations